Fabien Tinquaut

978 total citations
49 papers, 615 citations indexed

About

Fabien Tinquaut is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Geriatrics and Gerontology. According to data from OpenAlex, Fabien Tinquaut has authored 49 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 11 papers in Public Health, Environmental and Occupational Health and 10 papers in Geriatrics and Gerontology. Recurrent topics in Fabien Tinquaut's work include Frailty in Older Adults (7 papers), Cancer survivorship and care (6 papers) and Medication Adherence and Compliance (5 papers). Fabien Tinquaut is often cited by papers focused on Frailty in Older Adults (7 papers), Cancer survivorship and care (6 papers) and Medication Adherence and Compliance (5 papers). Fabien Tinquaut collaborates with scholars based in France, Italy and Canada. Fabien Tinquaut's co-authors include Franck Chauvin, Aurélie Bourmaud, Claire Falandry, Nicolas Magné, Mathieu Oriol, Gilles Freyer, Laëtitia Stefani, Éric Pujade-Lauraine, Olivier Trédan and Aude-Marie Savoye and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Fabien Tinquaut

44 papers receiving 609 citations

Peers

Fabien Tinquaut
Sandra Turner Australia
Elise M. Pelletier United States
Núria Porta United Kingdom
Xiaopan Li China
Megumi Hori Japan
Timothy C. Evans United States
Mathias Worni Switzerland
Stéphanie Bellec France
Ming Xue China
Wei Xian China
Sandra Turner Australia
Fabien Tinquaut
Citations per year, relative to Fabien Tinquaut Fabien Tinquaut (= 1×) peers Sandra Turner

Countries citing papers authored by Fabien Tinquaut

Since Specialization
Citations

This map shows the geographic impact of Fabien Tinquaut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabien Tinquaut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabien Tinquaut more than expected).

Fields of papers citing papers by Fabien Tinquaut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabien Tinquaut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabien Tinquaut. The network helps show where Fabien Tinquaut may publish in the future.

Co-authorship network of co-authors of Fabien Tinquaut

This figure shows the co-authorship network connecting the top 25 collaborators of Fabien Tinquaut. A scholar is included among the top collaborators of Fabien Tinquaut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabien Tinquaut. Fabien Tinquaut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bourmaud, Aurélie, Fabien Tinquaut, Mathieu Oriol, et al.. (2023). Patient navigation for colorectal cancer screening in deprived areas: the COLONAV cluster randomized controlled trial. BMC Cancer. 23(1). 21–21. 3 indexed citations
2.
Lafaie, Ludovic, Nicolas Magné, Wafa Bouleftour, et al.. (2023). Impact of Medical Specialties on Diagnostic and Therapeutic Management of Elderly Cancer Patients. Geriatrics. 8(3). 62–62.
3.
Falandry, Claire, Fanny Pommeret, Laurence Gladieff, et al.. (2022). Validation of the geriatric vulnerability score in older patients with ovarian cancer: an analysis from the GCIG-ENGOT-GINECO EWOC-1 study. The Lancet Healthy Longevity. 3(3). e176–e185. 7 indexed citations
4.
Magné, Nicolas, Jérôme Fayette, Élisabeth Daguenet, et al.. (2021). Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub‐analysis of the ProfiLER protocol. Head & Neck. 43(12). 3899–3910. 2 indexed citations
5.
Bouleftour, Wafa, et al.. (2021). Evaluation of a safe infusion device on reducing occupational exposure of nurses to antineoplastic drugs: a comparative prospective study. Contamoins-1. International Archives of Occupational and Environmental Health. 94(6). 1317–1325. 4 indexed citations
6.
7.
Balsat, Marie, Sylvie Pillet, Emmanuelle Tavernier, et al.. (2019). Human herpesvirus 6 infection after autologous stem cell transplantation: A multicenter prospective study in adult patients. Journal of Infection. 79(1). 36–42. 9 indexed citations
8.
Vallard, Alexis, Fabien Tinquaut, Franck Chauvin, et al.. (2019). Drug Management in End-of-Life Hospitalized Palliative Care Cancer Patients: The RHESO Cohort Study. Oncology. 97(4). 217–227. 5 indexed citations
9.
Rivoirard, Romain, Julien Langrand-Escure, Mathieu Oriol, et al.. (2018). Evaluation of the quality of the reporting of phase II clinical trials in oncology: A systematic review. Critical Reviews in Oncology/Hematology. 125. 78–83. 1 indexed citations
10.
Guillot, Aline, Philippe Barthélémy, Sylvie Négrier, et al.. (2018). Denosumab Toxicity When Combined With Anti-angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG Study. Clinical Genitourinary Cancer. 17(1). e38–e43. 13 indexed citations
11.
Oriol, Mathieu, Sophie Espenel, Fabien Tinquaut, et al.. (2018). Cancer patients treated with intravenous chemotherapy for the first time. What are their needs? What do they lack? A qualitative–quantitative mixed approach. Patient Preference and Adherence. Volume 12. 1853–1861. 5 indexed citations
12.
Azoulay, Élie, Djamel Mokart, Márcio Soares, et al.. (2018). Influence of neutropenia on mortality of critically ill cancer patients: results of a meta-analysis on individual data. Critical Care. 22(1). 326–326. 40 indexed citations
13.
Langrand-Escure, Julien, Romain Rivoirard, Mathieu Oriol, et al.. (2017). Quality of reporting in oncology phase II trials: A 5-year assessment through systematic review. PLoS ONE. 12(12). e0185536–e0185536. 8 indexed citations
14.
15.
Guillot, Aline, Philippe Barthélémy, Sylvie Négrier, et al.. (2016). Denosumab in patients with bone metastases from renal-cell carcinoma treated with anti-angiogenic therapy: a retrospective study from the GETUG (Groupe Etude des Tumeurs Uro Genitales). Annals of Oncology. 27. vi289–vi289. 3 indexed citations
16.
Bourmaud, Aurélie, Véronique Régnier Denois, Olivier Collard, et al.. (2016). Improving Adherence to Adjuvant Endocrine Therapy in Breast Cancer Through a Therapeutic Educational Approach: A Feasibility Study. Oncology nursing forum. 43(3). E94–E103. 12 indexed citations
17.
Bourmaud, Aurélie, Émilie Hénin, Fabien Tinquaut, et al.. (2015). Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods. BMC Research Notes. 8(1). 291–291. 21 indexed citations
18.
Bourmaud, Aurélie, Fabien Tinquaut, Mathieu Oriol, et al.. (2015). Social inequalities and cancer: can the European deprivation index predict patients' difficulties in health care access? a pilot study. Oncotarget. 7(1). 1055–1065. 25 indexed citations
19.
Bourmaud, Aurélie, et al.. (2014). Is oral chemotherapy prescription safe for patients? A cross-sectional survey. Annals of Oncology. 25(2). 500–504. 20 indexed citations
20.
Falandry, Claire, B. Weber, Aude-Marie Savoye, et al.. (2013). Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial. Annals of Oncology. 24(11). 2808–2813. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra Turner Breakdown of academic impact, for papers by Elise M. Pelletier Breakdown of academic impact, for papers by Núria Porta Breakdown of academic impact, for papers by Xiaopan Li Breakdown of academic impact, for papers by Megumi Hori Breakdown of academic impact, for papers by Timothy C. Evans Breakdown of academic impact, for papers by Mathias Worni Breakdown of academic impact, for papers by Stéphanie Bellec Breakdown of academic impact, for papers by Ming Xue Breakdown of academic impact, for papers by Wei Xian
Rankless by CCL
2026